Potential roles for the PIM1 kinase in human cancer - A molecular and therapeutic appraisal

被引:126
|
作者
Shah, Nilesh [2 ]
Pang, Brendan [1 ]
Yeoh, Khay-Guan [2 ,3 ]
Thorn, Shannon [4 ]
Chen, Chien Shiny [2 ,3 ]
Lilly, Michael B. [5 ]
Salto-Tellez, Manuel [1 ,2 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Pathol, Singapore 117595, Singapore
[2] Natl Univ Singapore, Oncol Res Inst, Singapore 117595, Singapore
[3] Natl Univ Singapore, Yong Loo Lin Sch Med, Natl Univ Hosp, Dept Med, Singapore 117595, Singapore
[4] Univ Arizona, Arizona Hlth Sci Ctr, Dept Med, Infect Dis Sect, Tucson, AZ USA
[5] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA
关键词
PIM1; Kinase; Lymphomas; Carcinomas; Target inhibitors;
D O I
10.1016/j.ejca.2008.06.044
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In vitro experiments have shown the PIM1 kinase to have diverse biological roles in cell survival, proliferation and differentiation. In humans, PIM1 is often expressed in both normal and transformed cells. The PIM1 kinase is a true oncogene implicated in early transformation and tumour progression in haematopoietic malignancies and prostate carcinomas. it is associated with aggressive subgroups of lymphoma, is a marker of poor prognosis in prostate carcinomas and has been suggested to have a role in hormone insensitivity of prostate malignancies. PIM1 has a possible role in other carcinomas with 6p21 genomic alterations. On one hand, PIM1 (due to its role in malignancy) appears to be a promising target for drug development programmes but, on the other hand, the complexity of its molecular structure has posed challenges in the development of PIM1 inhibitors. In this review we discuss PIM1 expression in human tissues (including some new data from our laboratory), its role in human malignancies, as well as the possibilities and challenges in the development of target therapy for PIM1. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2144 / 2151
页数:8
相关论文
共 50 条
  • [21] PIM1 is a Poor Prognostic Factor for and Potential Therapeutic Target in Serous Carcinoma of the Endometrium
    Takeuchi, Hodaka
    Miyamoto, Tsutomu
    Fuseya, Chiho
    Asaka, Ryoichi
    Ida, Koichi
    Ono, Motoki
    Tanaka, Yasuhiro
    Shinagawa, Manaka
    Ando, Hirofumi
    Asaka, Shiho
    Shiozawa, Tanri
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (03) : 282 - 292
  • [22] Inhibition of Pim1 kinase, new therapeutic approach in virus-induced asthma exacerbations
    de Vries, Maaike
    Bedke, Nicole
    Smithers, Natalie P.
    Loxham, Matthew
    Howarth, Peter H.
    Nawijn, Martijn C.
    Davies, Donna E.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (03) : 783 - 791
  • [23] PIM1 kinase as a promise of targeted therapy in prostate cancer stem cells (Review)
    Xie, yingqiu
    Bayakhmetov, Samat
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (01) : 13 - 17
  • [24] PIM1 signaling in immunoinflammatory diseases: an emerging therapeutic target
    Yang, Xue
    Liu, Chunming
    Lei, Yuxi
    Liu, Zhi
    Zhu, Bin
    Zhao, Dongchi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] Regulation of prostate stromal fibroblasts by the PIM1 protein kinase
    Zemskova, Marina Y.
    Song, Jin H.
    Cen, Bo
    Cerda-Infante, Javier
    Montecinos, Viviana P.
    Kraft, Andrew S.
    CELLULAR SIGNALLING, 2015, 27 (01) : 135 - 146
  • [26] Personalizing cardiac regenerative therapy: At the heart of Pim1 kinase
    Samse, Kaitlen
    Hariharan, Nirmala
    Sussman, Mark A.
    PHARMACOLOGICAL RESEARCH, 2016, 103 : 13 - 16
  • [27] PIM1 kinase and its diverse substrate in solid tumors
    Choudhury, Rituparna
    Bahadi, Chandan Kumar
    Ray, Ipsa Pratibimbita
    Dash, Pragyanshree
    Pattanaik, Isha
    Mishra, Suman
    Mohapatra, Soumya R.
    Patnaik, Srinivas
    Nikhil, Kumar
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [28] Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
    Wang, J.
    Anderson, P. D.
    Luo, W.
    Gius, D.
    Roh, M.
    Abdulkadir, S. A.
    ONCOGENE, 2012, 31 (14) : 1794 - 1803
  • [29] Why target PIM1 for cancer diagnosis and treatment?
    Magnuson, Nancy S.
    Wang, Zeping
    Ding, Gang
    Reeves, Raymond
    FUTURE ONCOLOGY, 2010, 6 (09) : 1461 - 1478
  • [30] Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells
    J Wang
    P D Anderson
    W Luo
    D Gius
    M Roh
    S A Abdulkadir
    Oncogene, 2012, 31 : 1794 - 1803